TOVX: Theriva Biologics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
26 institutions reported holding $474K of Theriva Biologics, Inc. on Form 13F (22 the quarter before). 6 opened a new position and 2 sold out. Shares held by institutions: +11%.
| Largest holders | Shares | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 486,179 | $122K |
| JANE STREET GROUP, LLC | 331,922 | $83K |
| GEODE CAPITAL MANAGEMENT, LLC | 294,021 | $74K |
| VANGUARD FIDUCIARY TRUST CO | 241,780 | $60K |
| Ikarian Capital, LLC | 112,076 | $28K |
| NORTHERN TRUST CORP | 82,700 | $21K |
| RENAISSANCE TECHNOLOGIES LLC | 63,710 | $16K |
| UBS Group AG | 61,053 | $15K |
| XTX Topco Ltd | 53,868 | $13K |
| Ground Swell Capital, LLC | 35,292 | $9K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.